Institutional investors purchased a net $334.5 thousand shares of MNKD during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 19.74% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SCOPIA CAPITAL MANAGEMENT LP Bought 4.9 Million shares of MannKind Corp
BLACKROCK FUND ADVISORS Bought 3.8 Million shares of MannKind Corp
THE VANGUARD GROUP, INC. Bought 2.8 Million shares of MannKind Corp